DK0681573T3 - C2-taxanderivater og farmaceutiske præparater indeholdende disse - Google Patents

C2-taxanderivater og farmaceutiske præparater indeholdende disse

Info

Publication number
DK0681573T3
DK0681573T3 DK94907959T DK94907959T DK0681573T3 DK 0681573 T3 DK0681573 T3 DK 0681573T3 DK 94907959 T DK94907959 T DK 94907959T DK 94907959 T DK94907959 T DK 94907959T DK 0681573 T3 DK0681573 T3 DK 0681573T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
taxane derivatives
compositions containing
substituent
taxane
Prior art date
Application number
DK94907959T
Other languages
English (en)
Inventor
Robert A Holton
Chunlin Tao
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Univ Florida State filed Critical Univ Florida State
Application granted granted Critical
Publication of DK0681573T3 publication Critical patent/DK0681573T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94907959T 1993-01-29 1994-01-28 C2-taxanderivater og farmaceutiske præparater indeholdende disse DK0681573T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9471593A 1993-07-20 1993-07-20
PCT/US1994/001223 WO1994017052A1 (en) 1993-01-29 1994-01-28 C2 taxane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK0681573T3 true DK0681573T3 (da) 2002-10-28

Family

ID=27359309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94907959T DK0681573T3 (da) 1993-01-29 1994-01-28 C2-taxanderivater og farmaceutiske præparater indeholdende disse

Country Status (13)

Country Link
EP (2) EP0681573B1 (da)
JP (2) JP3452928B2 (da)
CN (1) CN1125061C (da)
AT (2) ATE220064T1 (da)
AU (2) AU685778B2 (da)
CA (2) CA2155013C (da)
DE (2) DE69430902T2 (da)
DK (1) DK0681573T3 (da)
ES (1) ES2176237T3 (da)
IL (1) IL108444A0 (da)
PT (1) PT681573E (da)
TW (2) TW360646B (da)
WO (2) WO1994017052A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
FR2702212B1 (fr) * 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
FR2723094A1 (fr) * 1994-07-26 1996-02-02 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
CA2328771A1 (en) * 1997-12-31 1999-07-08 Bristol-Myers Squibb Company 2-aroyl-4-acyl paclitaxel (taxol) analogs
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
AU2005245396A1 (en) * 2004-05-14 2005-12-01 Immunogen, Inc. A facile method for synthesizing baccatin III compounds
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN104250235B (zh) * 2014-09-24 2016-10-05 江苏红豆杉药业有限公司 一种紫杉醇的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol

Also Published As

Publication number Publication date
AU6234094A (en) 1994-08-15
CA2155014A1 (en) 1994-08-04
DE69430661D1 (de) 2002-06-27
AU685778B2 (en) 1998-01-29
TW402598B (en) 2000-08-21
JP3741715B2 (ja) 2006-02-01
CA2155014C (en) 2007-06-26
AU6132794A (en) 1994-08-15
EP0681575B1 (en) 2002-05-22
DE69430902D1 (de) 2002-08-08
CN1125061C (zh) 2003-10-22
CA2155013A1 (en) 1994-08-04
WO1994017051A1 (en) 1994-08-04
DE69430661T2 (de) 2002-10-24
TW360646B (en) 1999-06-11
DE69430902T2 (de) 2002-10-24
EP0681575A4 (da) 1995-12-13
WO1994017052A1 (en) 1994-08-04
EP0681575A1 (en) 1995-11-15
AU684268B2 (en) 1997-12-11
EP0681573B1 (en) 2002-07-03
CA2155013C (en) 2006-04-11
JP3452928B2 (ja) 2003-10-06
ATE220064T1 (de) 2002-07-15
EP0681573A1 (en) 1995-11-15
ES2176237T3 (es) 2002-12-01
ATE217870T1 (de) 2002-06-15
CN1101346A (zh) 1995-04-12
EP0681573A4 (da) 1995-12-06
PT681573E (pt) 2002-11-29
JPH10502327A (ja) 1998-03-03
JPH08506326A (ja) 1996-07-09
IL108444A0 (en) 1994-04-12

Similar Documents

Publication Publication Date Title
NL350077I1 (nl) Cyprosulfamide
TR199800825T2 (xx) Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
DE69430611D1 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
DK0705254T3 (da) Phenylheterocykliske forbindelser som cyclooxygenase-2-inhibitorer
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
DK0681573T3 (da) C2-taxanderivater og farmaceutiske præparater indeholdende disse
DE69317764D1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE423562T1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
BR9711586A (pt) Compostos e uso dos mesmo
TR199800182T1 (xx) 2-oksazolidinon t�revlerinin bir kapta sentezi.
EA200000320A1 (ru) Изохинолины в качестве ингибиторов урокиназы
SE7714660L (sv) Aminosockerderivat, sett for framstellning derav samt anvendning derav som lekemedel
DK1275389T3 (da) Præparater indeholdende C7-taxaner
MX9203845A (es) Nuevos benzomorfanos, procedimieto para su preparacion y composiciones farmaceuticas que los contienen.
FI950842A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
TR199701298T1 (xx) Tetralinler.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
ID23783A (id) Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
JPS52100439A (en) Omega-(arysulfonamido)alkylamines